Search

Your search keyword '"Eeckt, Kathy Vander"' showing total 12 results
Start Over Author "Eeckt, Kathy Vander"
12 results on '"Eeckt, Kathy Vander"'

5. OUTCOME OF MULTIMODALITY TREATMENT WITH RADICAL PROSTATECTOMY AS INITIAL STEP FOR PROSTATE CANCER WITH PSA >20 NG/ML: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 801 PATIENTS: 1279

Author

Spahn, Martin, Gontero, Paolo, Joniau, Steven, Tombal, Bertrand, Bangma, Chris H, Walz, Jochen, Eeckt, Kathy Vander, Bader, Pia, Hsu, Chao-Yu, Marchioro, Giansilvio, Isbarn, Hendrik, Frohneberg, Detlef, Graefen, Markus, Schröder, Fritz H, Tizzani, Alessandro, Van Cangh, Paul, and Van Poppel, Hein

Published
2009

6. RECURRENCE AND PROGRESSION ACCORDING TO STAGE AT RE-TUR IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BCG: NOT AS BAD AS PREVIOUSLY THOUGHT

Author

Palou, Joan, Gontero, Paolo, Pisano, Francesca, Joniau, Steven, Eeckt, Kathy Vander, Oderda, Marco, Serretta, Vincenzo, Larre, Stephane, Di Stasi, Savino, Rhijn, Bas, Witjes, Alfred J., Grotenhuis, Anne, Colombo, Renzo, Briganti, Alberto, Babjuk, Amrek, Viktor Soukup, Malmstrom, Per Uno, Irani, Jaques, Malats, Nuria, Baniel, Jack, Mano, Roy, Cai, Tommaso, Cha, Eugene, Ardelt, Peter, Varkarakis, John, Bartoletti, Riccardo, Sphan, Martin, Dalbagni, Guido, Shariat, Shahrokh F., Xylinas, Evangelous, Karnes, R. Jeffrey, Sylvester, Richard, Palou, J., Gontero, P., Pisano, F., Joniau, S., Eeckt, KV, Oderda, M., Serretta, V., Larrè, S., Di Stasi, S., Van Rhijn, B., Witjes, A., Grotenhuis, A., Colombo, R., Briganti, A., Babjuk, M., Soukup, V., Malmstrom, P., Irani, J., Malats, N., Baniel, J., Mano, R., Cai, T., Cha, E., Ardelt, P., Varkarakis, J., Bartoletti, R., Sphan, M, Dalbagni, G., Shariat, S., Xylinas, E., Karnes, R., and Sylvester, R.

Subjects
Bladder cancer, BCG, T1HG, re-TUR, Settore MED/24 - Urologia
Published
2017

8. Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guerin : Results of a Retrospective Multicenter Study of 2451 Patients

Author

Gontero, Paolo, Sylvester, Richard, Pisano, Francesca, Joniau, Steven, Eeckt, Kathy Vander, Serretta, Vincenzo, Larre, Stephane, Di Stasi, Savino, Van Rhijn, Bas, Witjes, Alfred J., Grotenhuis, Anne J., Kiemeney, Lambertus A., Colombo, Renzo, Briganti, Alberto, Babjuk, Marek, Malmström, Per-Uno, Oderda, Marco, Irani, Jacques, Malats, Nuria, Baniel, Jack, Mano, Roy, Cai, Tommaso, Cha, Eugene K., Ardelt, Peter, Varkarakis, John, Bartoletti, Riccardo, Spahn, Martin, Johansson, Robert, Frea, Bruno, Soukup, Viktor, Xylinas, Evanguelos, Dalbagni, Guido, Karnes, R. Jeffrey, Shariat, Shahrokh F., Palou, Joan, Gontero, Paolo, Sylvester, Richard, Pisano, Francesca, Joniau, Steven, Eeckt, Kathy Vander, Serretta, Vincenzo, Larre, Stephane, Di Stasi, Savino, Van Rhijn, Bas, Witjes, Alfred J., Grotenhuis, Anne J., Kiemeney, Lambertus A., Colombo, Renzo, Briganti, Alberto, Babjuk, Marek, Malmström, Per-Uno, Oderda, Marco, Irani, Jacques, Malats, Nuria, Baniel, Jack, Mano, Roy, Cai, Tommaso, Cha, Eugene K., Ardelt, Peter, Varkarakis, John, Bartoletti, Riccardo, Spahn, Martin, Johansson, Robert, Frea, Bruno, Soukup, Viktor, Xylinas, Evanguelos, Dalbagni, Guido, Karnes, R. Jeffrey, Shariat, Shahrokh F., and Palou, Joan

Abstract

Background: The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critical for proper treatment decision making. Objective: To assess prognostic factors in patients who received bacillus Calmette Guerin (BCG) as initial intravesical treatment of T1G3 tumors and to identify a subgroup of high-risk patients who should be considered for more aggressive treatment. Design, setting, and participants: Individual patient data were collected for 2451 T1G3 patients from 23 centers who received BCG between 1990 and 2011. Outcome measurements and statistical analysis: Using Cox multivariable regression, the prognostic importance of several clinical variables was assessed for time to recurrence, progression, BCa-specific survival, and overall survival (OS). Results and limitations: With a median follow-up of 5.2 yr, 465 patients (19%) progressed, 509 (21%) underwent cystectomy, and 221 (9%) died because of BCa. In multivariable analyses, the most important prognostic factors for progression were age, tumor size, and concomitant carcinoma in situ (CIS); the most important prognostic factors for BCa-specific survival and OS were age and tumor size. Patients were divided into four risk groups for progression according to the number of adverse factors among age >= 70 yr, size >= 3 cm, and presence of CIS. Progression rates at 10 yr ranged from 17% to 52%. BCa-specific death rates at 10 yr were 32% in patients >= 70 yr with tumor size >= 3 cm and 13% otherwise. Conclusions: T1G3 patients >= 70 yr with tumors >= 3 cm and concomitant CIS should be treated more aggressively because of the high risk of progression. Patient summary: Although the majority of T1G3 patients can be safely treated with intravesical bacillus Calmette-Guerin, there is a subgroup of T1G3 patients with age >= 70 yr, tumor size >= 3 cm, and concomitant CIS who have a high risk of progression and thus require aggressive treatment.

Published
2015
Full Text
View/download PDF

9. Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg : Results Of A Multicenter Retrospective Series In 1743 Patients

Author

Gonterol, P., Sylvester, R., Pisano, F., Joniau, S., Eeckt, Kathy Vander, Serretta, V., Larre, S., di Stasi, S., Van Rhijn, B., Witjes, A., Grotenhuis, A., Colombo, R., Brigand, A., Babjukl, M., Soukupw, V., Malmström, Per-Uno, Irani, J., Malats, N., Baniel, J., Mano, R., Cai, T., Cha, E., Ardelti, P., Vakarakisis, J., Bartoletti, R., Sphan, M., Dalbagnin, G., Shariat, S. F., Karnes, J., Palou, J., Gonterol, P., Sylvester, R., Pisano, F., Joniau, S., Eeckt, Kathy Vander, Serretta, V., Larre, S., di Stasi, S., Van Rhijn, B., Witjes, A., Grotenhuis, A., Colombo, R., Brigand, A., Babjukl, M., Soukupw, V., Malmström, Per-Uno, Irani, J., Malats, N., Baniel, J., Mano, R., Cai, T., Cha, E., Ardelti, P., Vakarakisis, J., Bartoletti, R., Sphan, M., Dalbagnin, G., Shariat, S. F., Karnes, J., and Palou, J.

Published
2013

10. OUTCOME OF MULTIMODALITY TREATMENT OF HIGH-RISK LOCALIZED PROSTATE CANCER (CT3-4 OR PSA ≥20 NG/ML OR BIOPSY GLEASON SCORE ≥8) WITH RADICAL PROSTATECTOMY AS INITIAL STEP: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 1413 PATIENTS

Author

Joniau, Steven, primary, Spahn, Martin, additional, Gontero, Paolo, additional, Tombal, Bertrand, additional, Bangma, Chris H, additional, Walz, Jochen, additional, Hsu, Chao-Yu, additional, Eeckt, Kathy Vander, additional, Marchioro, Giansilvio, additional, Bader, Pia, additional, Isbarn, Hendrik, additional, Frohneberg, Detlef, additional, Graefen, Markus, additional, Schröder, Fritz H, additional, Tizzani, Alessandro, additional, Van Cangh, Paul, additional, and Van Poppel, Hein, additional

Published
2009
Full Text
View/download PDF

11. RADICAL PROSTATECTOMY IN VERY HIGH RISK LOCALIZED PROSTATE CANCER

Author

Gontero, Paolo, primary, Joniau, Steven, additional, Spahn, Martin, additional, Tombal, Bertrand, additional, Eeckt, Kathy Vander, additional, Bader, Pia, additional, Frohneberg, Detlef, additional, Tizzani, Alessandro, additional, Van Cangh, Paul, additional, and Van Poppel, Hein, additional

Published
2009
Full Text
View/download PDF

12. RISK FACTORS FOR RESIDUAL DISEASE AT RE-TUR IN T1G3 BLADDER CANCER

Author

Palou, Joan, Sylvester, Richard, Pisano, Francesca, Joniau, Steven, Eeckt, Kathy Vander, Oderda, Marco, Serretta, Vincenzo, Larre, Stephane, Di Stasi, Savino, Rhijn, Bas, Witjes, Alfred J., Grotenhuis, Anne, Colombo, Renzo, Briganti, Alberto, Babjuk, Amrek, Viktor Soukup, Malmstrom, Per Uno, Irani, Jaques, Malats, Nuria, Baniel, Jack, Mano, Roy, Cai, Tommaso, Cha, Eugene, Ardelt, Peter, Varkarakis, John, Bartoletti, Riccardo, Sphan, Martin, Dalbagni, Guido, Shariat, Shahrokh F., Xylinas, Evangelous, Karnes, R. Jeffrey, Gontero, Paolo, Palou, J., Gontero, P., Pisano, F., Joniau, S., Eeckt, K., Oderda, M., Serretta, V., Larrè, S., Di Stasi, S., Van Rhijn, B., Witjes, A., Grotenhuis, A., Colombo, R., Briganti, A., Babjuk, M., Soukup, V., Malmstrom, P., Irani, J., Malats, N., Baniel, J., Mano, R., Cai, T., Cha, E., Ardelt, P., Varkarakis, J., Bartoletti, R., Sphan, M., Dalbagni, G., Shariat, S., Xylinas, E., Karnes, R., and Sylvester, R.

Subjects
Bladder cancer, T1HG, re-TUR, BCG, Settore MED/24 - Urologia

Catalog

Books, media, physical & digital resources
See catalog results